Purple Biotech Ltd.
PPBT· Nasdaq
PPBTPurple Biotech Ltd.
Who holds Purple Biotech Ltd., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| SmartHarvest Portfolios, LLC | 28.5K | +57.0% | $47.8K | 0.1% | Aug 4, 2026 |
| Citadel Advisors LLC | 13.2K | New | $22.1K | 0% | Sep 2, 2026 |
| Susquehanna International Group, LLP | 12.8K | −75.9% | $21.6K | 0% | Aug 14, 2026 |
| Independent Advisor Alliance | 11.9K | New | $20K | 0.1% | Aug 12, 2026 |
| Arax Advisory Partners | 1.5K | New | $2.4K | 0% | Aug 10, 2026 |
| Rhumbline Advisers | 856 | +20.6% | $1.4K | 0% | Aug 12, 2026 |
| UBS Group AG | 751 | +658.6% | $1.3K | 0% | Aug 13, 2026 |
| Morgan Stanley | 197 | −65.9% | $331 | 0% | Aug 13, 2026 |
| HRT Financial LP | 14.6K | New | $24 | 0% | Aug 14, 2026 |
| Northwestern Mutual Wealth Management Co | 8 | ±0% | $13 | 0% | Aug 12, 2026 |
| IFG Advisory, LLC | 7 | New | $12 | 0% | Aug 14, 2026 |
| SBI Securities Co., Ltd. | 3 | −90.3% | $5 | 0% | Jul 23, 2026 |
| Royal Bank of Canada | 128 | +1,180.0% | $0 | 0% | Aug 14, 2026 |
